Related Experiment Video
Updated: Mar 31, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated
J Berscheminski1, J Brun1, T Speiseder1
1Department of Viral Transformation, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Abstract:
Human adenoviruses (HAdV) are used as a model system to investigate tumorigenic processes in mammalian cells where the viral oncoproteins E1A and E1B-55K are absolutely required for oncogenic transformation, because they simultaneously accelerate cell cycle progression and inhibit tumor suppressor proteins such as p53, although the underlying mechanism is still not understood in detail. In our present study, we provide evidence that E1B-55K binding to the PML-NB component Sp100A apparently has an essential role in regulating adenovirus-mediated transformation processes. Specifically, when this E1B-55K/Sp100A complex recruits p53, Sp100A-induced activation of p53 transcriptional activity is effectively abolished. Hence, Sp100A exhibits tumor-suppressive activity, not only by stabilizing p53 transactivation but also by depressing E1A/E1B-55K-mediated transformation. E1B-55K counteracts this suppressive activity, inducing Sp100A SUMOylation and sequestering the modified cellular factor into the insoluble matrix of the nucleus or into cytoplasmic inclusions. These observations provide novel insights into how E1B-55K modulates cellular determinants to maintain growth-promoting activity during oncogenic processes and lytic infection.
Insights
Human adenoviruses use oncoproteins E1A and E1B-55K for oncogenic transformation. The viral E1B-55K protein interacts with Sp100A, inhibiting its tumor-suppressive activity and promoting cell cycle progression.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- Human adenoviruses (HAdV) are models for studying cancer development.
- Viral oncoproteins E1A and E1B-55K are crucial for oncogenic transformation.
- These oncoproteins accelerate cell cycle progression and inhibit tumor suppressors like p53.
Purpose of the Study:
- To investigate the role of E1B-55K binding to Sp100A in adenovirus-mediated transformation.
- To elucidate the mechanism by which Sp100A regulates p53 activity and tumor suppression.
- To understand how E1B-55K counteracts Sp100A's tumor-suppressive functions.
Main Methods:
- Studying the interaction between viral oncoprotein E1B-55K and PML-NB component Sp100A.
- Analyzing the effect of the E1B-55K/Sp100A complex on p53 transcriptional activity.
- Investigating Sp100A SUMOylation and cellular localization induced by E1B-55K.
Main Results:
- E1B-55K binding to Sp100A is essential for adenovirus-driven transformation.
- The E1B-55K/Sp100A complex inhibits Sp100A-mediated p53 activation.
- Sp100A exhibits tumor-suppressive activity by stabilizing p53 and hindering transformation.
- E1B-55K counteracts Sp100A's suppression via SUMOylation and altered localization.
Conclusions:
- Sp100A acts as a tumor suppressor by modulating p53 activity.
- E1B-55K manipulates Sp100A to promote viral oncogenesis and lytic infection.
- These findings offer new insights into viral oncoprotein strategies for cellular control.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
The Intrinsic Apoptotic Pathway

